The frequency of coexistent cardio-metabolic diseases in COVID-19 patients and their effects on clinical outcomes

Q: What is the clinical evidence from this study?

Study design: Observational. Population: COVID-19 (n=159). Intervention: Cardio-metabolic comorbidities vs. No cardio-metabolic comorbidities. Primary outcome: Frequency of at least one cardio-metabolic comorbidity.

Mehmet Uzunlulu; Haluk Vahapohlu; Ayse Naciye Erbakan; Ümmügülsüm DURAK; Lütfullah Caştur; Onur İncealtın; Özlem Altuntaş Aydın

doi:10.35514/mtd.2021.57

December 31, 2021Maltepe Tıp DergisiOpen Access

The frequency of coexistent cardio-metabolic diseases in COVID-19 patients and their effects on clinical outcomes

View Full Paper

Ask AI

Bookmark

Share

Study Design

Type

Observational (n=159)

Multicenter

No

Structured PICO

P

Population

159 adult patients hospitalized with PCR-confirmed COVID-19, evaluated retrospectively to determine the frequency and clinical impact of cardio-metabolic comorbidities.

C

Comparator

COVID-19 PCR negative cases (n=154)

O

Outcome

Determination of the frequencies of cardio-metabolic comorbid diseases such as hypertension, diabetes mellitus, coronary artery disease, congestive heart failure, hyperlipidemia, chronic kidney disease, and cerebrovascular disease

Limitations

Retrospective design based on hospital records
Uncertainty of the duration of comorbidity
Lack of distinction between type 1 and type 2 diabetes
Patients admitted directly to the ICU were not included
Retrospective design
Based on hospital records
Exclusion of patients admitted directly to the ICU

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

The clustering of multiple cardio-metabolic comorbidities, rather than their individual presence, is associated with increased risk of mortality and ICU admission in hospitalized COVID-19 patients.

Abstract

We aimed to determine the frequency and characteristics of cardio-metabolic comorbidities (CMC) in patients hospitalized with the diagnosis of COVID-19 disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Uzunlulu et al. (2021) conducted an observational in COVID-19 (n=159). Cardio-metabolic comorbidities vs. No cardio-metabolic comorbidities was evaluated on Frequency of at least one cardio-metabolic comorbidity.

synapsesocial.com/papers/6a7453834d9108bbdbdb60c2 https://doi.org/10.35514/mtd.2021.57

View Full Paper

Ask AI

Bookmark

Share

The frequency of coexistent cardio-metabolic diseases in COVID-19 patients and their effects on clinical outcomes

Study Design

Structured PICO

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

The frequency of coexistent cardio-metabolic diseases in COVID-19 patients and their effects on clinical outcomes

Study Design

Structured PICO

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading